Cookies?
Library Header Image
LSE Research Online LSE Library Services

How well do all patient refined–diagnosis-related groups explain costs of pediatric cancer chemotherapy admissions in the United States?

Russell, Heidi, Street, Andrew and Ho, Vivian (2016) How well do all patient refined–diagnosis-related groups explain costs of pediatric cancer chemotherapy admissions in the United States? Journal of oncology practice, 12 (5).

Full text not available from this repository.
Identification Number: 10.1200/JOP.2015.010330

Abstract

Purpose: State-based Medicaid programs have begun using All Patient Refined–Diagnosis-Related Groups (APR-DRGs) to determine hospital reimbursement rates. Medicaid provides coverage for 45% of childhood cancer admissions. This study aimed to examine how well APR-DRGs reflect admission costs for childhood cancer chemotherapy to inform clinicians, hospitals, and policymakers in the wake of policy changes. Methods: We identified 25,613 chemotherapy admissions in the 2009 Kids’ Inpatient Database. To determine how well APR-DRGs explain costs, we applied a hierarchic linear regression model of hospital costs, allowing for a variety of patient, hospital, and geographic confounders. Results: APR-DRGs proved to be the most important predictors of admission costs (P < .001), with costs increasing by DRG severity code. Diagnosis, age, and hospital characteristics also predicted costs above and beyond those explained by APR-DRGs. Compared with admissions for patients with acute lymphoblastic leukemia, costs of admissions for patients with acute myelomonocytic leukemia were 82% higher; non-Hodgkin lymphoma, 20% higher; Hodgkin lymphoma, 25% lower; and CNS tumors, 27% lower. Admissions for children who were 10 years of age or older cost 26% to 35% more than admissions for infants. Admissions to children’s hospitals cost 46% more than admissions to other hospital types. Conclusion: APR-DRGs developed for adults are applicable to childhood cancer chemotherapy but should be refined to account for cancer diagnosis and patient age. Possible policy and clinical management changes merit further study to address factors not captured by APR-DRGs.

Item Type: Article
Official URL: http://ascopubs.org/
Additional Information: © 2016 The Authors CC BY 4.0
Divisions: Health Policy
Subjects: R Medicine > R Medicine (General)
R Medicine > RG Gynecology and obstetrics
Sets: Departments > Health Policy
Date Deposited: 03 Oct 2017 13:41
Last Modified: 30 Jan 2019 20:33
URI: http://eprints.lse.ac.uk/id/eprint/84421

Actions (login required)

View Item View Item